Literature DB >> 11514647

Neuroactive steroid levels in patients with generalized anxiety disorder.

T Semeniuk1, G S Jhangri, J M Le Mellédo.   

Abstract

Serum levels of allopregnanolone, pregnenolone sulfate, and dehydroepiandrosterone sulfate were measured in 8 male patients with generalized anxiety disorder (GAD) and 8 healthy control subjects. Results suggest that patients with GAD have significantly lower levels of pregnenolone sulfate than control subjects.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11514647     DOI： 10.1176/jnp.13.3.396

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN： 0895-0172            Impact factor:   2.198


  10 in total

Review 1.  Neuroactive steroids and anxiety disorders.

Authors:  Jean-Michel Le Mellédo; Glen B Baker
Journal:  J Psychiatry Neurosci       Date:  2002-05       Impact factor: 6.186

2.  Amyloid Beta Peptides Affect Pregnenolone and Pregnenolone Sulfate Levels in PC-12 and SH-SY5Y Cells Depending on Cholesterol.

Authors:  Ozlem Gursoy Calan; Pinar Akan; Aysenur Cataler; Cumhur Dogan; Semra Kocturk
Journal:  Neurochem Res       Date:  2016-03-26       Impact factor: 3.996

3.  Neuropsychopharmacological properties of neuroactive steroids in depression and anxiety disorders.

Authors:  Daniela Eser; Cornelius Schüle; Elena Romeo; Thomas C Baghai; Flavia di Michele; Augusto Pasini; Peter Zwanzger; Frank Padberg; Rainer Rupprecht
Journal:  Psychopharmacology (Berl)       Date:  2005-10-25       Impact factor: 4.530

Review 4.  The relevance of neuroactive steroids in schizophrenia, depression, and anxiety disorders.

Authors:  Erin M MacKenzie; John Odontiadis; Jean-Michel Le Mellédo; Trevor I Prior; Glen B I Baker
Journal:  Cell Mol Neurobiol       Date:  2007-08       Impact factor: 5.046

Review 5.  Pregnenolone, dehydroepiandrosterone, and schizophrenia: alterations and clinical trials.

Authors:  Michael S Ritsner
Journal:  CNS Neurosci Ther       Date:  2010       Impact factor: 5.243

6.  Allopregnanolone elevations following pregnenolone administration are associated with enhanced activation of emotion regulation neurocircuits.

Authors:  Rebecca K Sripada; Christine E Marx; Anthony P King; Jessica C Rampton; S Shaun Ho; Israel Liberzon
Journal:  Biol Psychiatry       Date:  2013-01-21       Impact factor: 13.382

Review 7.  Sex differences in progestogen- and androgen-derived neurosteroids in vulnerability to alcohol and stress-related disorders.

Authors:  MacKenzie R Peltier; Terril L Verplaetse; Yann S Mineur; Ralitza Gueorguieva; Ismene Petrakis; Kelly P Cosgrove; Marina R Picciotto; Sherry A McKee
Journal:  Neuropharmacology       Date:  2021-02-16       Impact factor: 5.250

Review 8.  Anxiety disorders and GABA neurotransmission: a disturbance of modulation.

Authors:  Philippe Nuss
Journal:  Neuropsychiatr Dis Treat       Date:  2015-01-17       Impact factor: 2.570

9.  Comparative Untargeted Metabolomics Analysis of the Psychostimulants 3,4-Methylenedioxy-Methamphetamine (MDMA), Amphetamine, and the Novel Psychoactive Substance Mephedrone after Controlled Drug Administration to Humans.

Authors:  Andrea E Steuer; Daria Kaelin; Martina I Boxler; Lisa Eisenbeiss; Friederike Holze; Patrick Vizeli; Joanna Czerwinska; Paul I Dargan; Vincenzo Abbate; Matthias E Liechti; Thomas Kraemer
Journal:  Metabolites       Date:  2020-07-27

10.  Neurosteroid Levels in Patients with Obsessive-Compulsive Disorder.

Authors:  Lale Gonenir Erbay; Sukru Kartalci
Journal:  Psychiatry Investig       Date:  2015-09-30       Impact factor: 2.505
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.